Knowledge Distillery

Post-mortem studies have shown that patients dying from SARS-CoV-2 infection frequently have pathological changes in their CNS, particularly in the…

Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…

The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and…

In 2024, the sequalae of the acute phase of coronavirus disease-19 (COVID-19) infection, which include neurological symptoms and are commonly referred…

Between 2.5% and 28% of people infected with SARS-CoV-2 suffer long COVID or persistence of symptoms for months after acute illness. Many symptoms are…

Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019…

COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. In this study, the authors show…

Although some studies have shown neuroimaging and neuropsychological alterations in post-COVID-19 patients, fewer combined neuroimaging and…

The purpose of this prospective cohort study was to evaluate the possible correlation between SARS-CoV-2 vaccines and the onset of neurological…

Epidemiological studies showed that COVID-19 increases risk of Alzheimer's disease (AD). However, it remains unknown if there is a potential genetic…

Fatigue is a frequent and one of the most debilitating symptoms in post-COVID syndrome (PCS). Recently, the authors of this article proposed that…

A variety of neurologic disorders have been reported as presentations or complications of coronavirus disease 2019 (COVID-19) infection.